Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Astellas, Innocare, Innovent, Neuexcell, Radiopharm, Sol-Gel, Takeda, .
Biopharmas in Asia-Pacific raising money in public or private financings: Allink Biotherapeutics, Orum Therapeutics, Rezubio, Syremis Therapeutics, Syneron.
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Beren, Grifols, GSK, Johnson & Johnson, Mandos, Spero, Tolmar.
Biopharma happenings, including deals and partnerships, and other news in brief: Alvotech, Boehringer Ingelheim, Evaxion, Medipost, Merck, Nxera, Regeneron, Teikoku Seiyaku, Teva.